跳至主要内容
临床试验/NCT01479231
NCT01479231撤回1 期

Predictors of PPI Response in Eosinophilic Esophagitis

Mayo Clinic0 个研究点开始时间: 2012年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
撤回
发起方
Mayo Clinic
主要终点
Prevalence of Gastroesophageal Reflux Disease

研究概览

简要总结

The investigators will determine the prevalence of gastroesophageal reflux disease (GERD) in Eosinophilic Esophagitis (EoE) and importantly determine the predictors of response to Proton Pump Inhibitor (PPI) therapy in EoE. Moreover, the investigators will determine the effect of GERD on the location of esophageal eosinophilia.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age < 80 years of age
  • 14 eosinophils / hpf on biopsies from esophagus
  • Abnormal validated Mayo dysphagia questionnaire (MDQ-30) (question 2"yes", question 4 > "moderate" and question 7 > "once a week")
  • Clinically performed EGD with > 14 eosinophils/hpf completed within last 3 months

排除标准

  • Other cause of dysphagia identified at endoscopy (e.g. stricture, web, infection, ring, achalasia, esophageal neoplasm)
  • Dilatation of esophagus at time of index endoscopy
  • Treatment with topical steroid within 3 months of index endoscopy
  • Treatment with PPI in last 30 days prior to index EGD
  • Patient population - adults with EoE recruited from Mayo Clinic Rochester, MN patient population

研究组 & 干预措施

dexlansoprazole

Experimental

干预措施: dexlansoprazole (Drug)

结局指标

主要结局

Prevalence of Gastroesophageal Reflux Disease

时间窗: 24 hour

Prevalence of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis (EoE) Description: The definition of GERD is acid exposure time of \>4.2% over 24 hour period, as measured by pH monitoring.

次要结局

  • Heartburn/regurgitation(30 day)
  • Abnormal 24 hour acid exposure(24 hour)
  • Ratio of distal/proximal mean esophageal eosinophil number(6 weeks)
  • Mean distal eosinophil number(6 weeks)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeffrey A Alexander

MD

Mayo Clinic

相似试验